Karina Heras-Las
Toledo, CM 45007, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dual Inhibition of HIF-1α and HIF-2α as a Promising Treatment for VHL-Associated Hemangioblastomas: A Pilot Study Using Patient-Derived Primary Cell Cultures.
Journal: Biomedicines
Published: March 16, 2025
Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients.
Journal: Pulmonary pharmacology & therapeutics
Published: September 16, 2020
Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial.
Journal: BMJ open ophthalmology
Published: June 28, 2019
Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
Journal: Endocrine-related cancer
Published: April 24, 2018
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.
Journal: Orphanet journal of rare diseases
Published: May 01, 2017
Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Journal: Orphanet journal of rare diseases
Published: May 22, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026